Lab supply companies have been selling antibodies using manipulated images
Image changes that would get a paper retracted are widespread among suppliers.
Ars Technica
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Ars Technica.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Ars Technica (arstechnica.com), a Tier B publisher, filed this report on . CurrentWire published this page 4 hours later, on .
Signal breakdown
CurrentWire ranked this story 51.6 of 100 in the snapshot this page was rendered from.
- Freshness
- 22.1 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: story prominence, 8 of 10. How each signal is calculated.
Filed under Technology · International · News.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.